|
Volumn 23, Issue 5, 2001, Pages 611-619
|
Effect of mycophenolate mofetil on the progression of adriamycin nephropathy
a a |
Author keywords
Adriamycin nephropathy; Glomerulosclerosis; MMF; Mycofenolate mofetil; Proteinuria; Tubulointerstitial fibrosis
|
Indexed keywords
DOXORUBICIN;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DISEASE COURSE;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG RESPONSE;
FIBROSING ALVEOLITIS;
GLOMERULOSCLEROSIS;
KIDNEY DISEASE;
MALE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEINURIA;
RAT;
TREATMENT OUTCOME;
ANIMALS;
DISEASE MODELS, ANIMAL;
DOXORUBICIN;
IMMUNOHISTOCHEMISTRY;
KIDNEY;
KIDNEY FUNCTION TESTS;
MALE;
MYCOPHENOLIC ACID;
NEPHRITIS, INTERSTITIAL;
PROBABILITY;
RATS;
RATS, WISTAR;
REFERENCE VALUES;
TREATMENT OUTCOME;
|
EID: 0035159348
PISSN: 0886022X
EISSN: None
Source Type: Journal
DOI: 10.1081/JDI-100107357 Document Type: Article |
Times cited : (5)
|
References (21)
|